Use of colloids of chronic [32P] phosphate in treatment of solid tumors

Nuclear Medicine and Biology

Volumn 23, Issue 7, 1996, Pages 907-910

  Zubillaga, M B ^a   Boccio, J R ^a   Nicolini, J O ^b   Ughetti, R ^b   Lanari, E ^c   Caro, R A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Laboratorios Bacon SAIC   (Argentina)

^c Nuclear Medicine Department   (Argentina)

Author keywords

32P; Betatherapy; Brachytherapy; Rats; Treatment; Tumors

Indexed keywords

CHROMIUM PHOSPHATE P 32; GELATIN; PHOSPHORUS 32; CHROMIUM DERIVATIVE; CHROMIUM PHOSPHATE; PHOSPHATE; PHOSPHORUS; SODIUM DIHYDROGEN PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; INTRATUMORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RADIOISOTOPE THERAPY; RAT; ADENOCARCINOMA; ANIMAL; COLLOID; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; FEMALE; METABOLIC CLEARANCE RATE; METABOLISM; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ANIMALS; CHROMIUM COMPOUNDS; COLLOIDS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLIC CLEARANCE RATE; PHOSPHATES; PHOSPHORUS RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030250993     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00123-0     Document Type: Article

References (26)

1. 32P-chromic phosphate. J. Nucl. Med. 9, 562-566.
2. 32) for local irradiation of the central nervous system. Int. J. Appl. Radiat. Isotopes 18, 97-100.
3. 3. Bergqvist L., Sundberg R., Rydén S. and Strand S. E. (1987) The "critical colloid dose" in studies of reticuloendothelial function. J. Nucl. Med. 28, 1424-1429.
4. 4. Cingolani H. and Houssay A. (1989) Fisiología Humana, Vol. 3, 6th ed. El Ateneo, Argentina.
5. 5. Cohen Y., Ingrand J. and Caro R. A. (1968) Kinetics of disappearance of gelatin-protected radiogold colloids from the blood stream. Int. J. Appl. Radiat. Isotopes 19, 703-705.
6. 6. Crusinberry R. A., Kramolowsky E. V. and Loening S. A. (1987) Percutaneous transperineal placement of gold-198 seeds for treatment of carcinoma of the prostate. Prostate 11, 59-67.
7. 7. Czapski G. (1971) Radiation chemistry of oxygenated aqueous solutions. Annu. Rev. Phys. Chem. 22, 171-208.
8. 32P] chromic phosphate colloid in cystic brain tumors. Stereotact. Funct. Neurosurg. 59, 166-168.
9. 9. Gullino P. M., Pettigrew H. M. and Grantham F. H. (1975) N-Nitrosomethylurea as mammary gland carcinogen in rats. J. Natl. Cancer Inst. 54, 401-404.
10. 10. Houle S., Yip T. K., Shepherd F. A., et al. (1989) Hepatocellular carcinoma: Pilot trial of treatment with Y-90 microspheres. Radiology 172, 857-860.
11. 11. Lunsford L. D., Somaza S., Kondziolka D. and Flickinger J. C. (1995) Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J. Neurosurg. 82, 523-529.
12. 12. Marano P., Brizi M. G., Cellini N., Montemaggi P., Balducci M., Morganti A. G., Frontera D., Fadda G., De Franco A. and Vecchioli A. (1993) Diagnostic and therapeutic integration in ductal carcinoma of the head of the pancreas. Preliminary note. Radiol. Med. (Torino) 85, 615-624.
13. 13. McFee A. S., Ackerman N. B. and Loken M. K. (1963) The prevention of hepatic metastasis by the use of colloidal suspension of radioactive chromic phosphate. J. Nucl. Med. 4, 234.
14. 14. Mitta A. and Robles A. M. (1986) Quality control of radiopharmaceuticals, pp. 101-102. ALABISMN, Montevideo, Uruguay.
15. 15. Porter A. T., Blasko J. C., Grimm P. D., Reddy S. M. and Ragde H. (1995) Brachytherapy for prostate cancer. CA Cancer J. Clin. 45, 165-178.
16. 16. Priestly J. B. Jr. and Breyer D. C. (1992) Guided brachytherapy for treatment of confined prostate cancer. Urology 40, 27-32.
17. 32P chromic phosphate for the treatment of hemophilic arthropathy. J. Bone Joint Surg. [Am] 76A, 482-488.
18. 18. Rivera E. S., Andrade N., Martin G., Melito G., Cricco G., Mohamad N., Davio C., Caro R. and Bergoc R. M. (1994) Induction of mammary tumors in rat by intraperitoneal injection of NMU: Histopathology and estral cycle influence. Cancer Lett. 86, 223-228.
19. 19. Siegel H. J., Luck J. V., Siegel M. E., Quines C. and Anderson E. (1994) Hemarthrosis and synovitis associated with hemophilia: Clinical use of P-32 chromic phosphate synoviorthesis for treatment. Radiology 190, 257-261.
20. 20. Sokal R. R. and Rohlf F. J. (1981) Biometry. Freeman, San Francisco.
21. 21. Soper J. T., Berchuck A., Dodge R. and Clarke Pearson D. L. (1992) Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging. Obstet. Gynecol. 79, 993-997.
22. 22. Spanos W. J. Jr, Day T. Jr, Jose B., Paris K. and Lindberg R. D. (1994) Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol. Oncol. 54, 35-39.
23. 23. Tian Z. M. (1992) Stereotactic intracavitary irradiation of huge cystic craniopharyngiomas. Chung. Hua. Wai. Ko. Tsa. Chih. 30, 102-103, 125.
24. 24. Tian Z. M., Liu Z. H., Kang G. Q., Zhang Y., Li S. Y., Chen X. H., Chui Y. and Feng H. (1992) CT-guided stereotactic injection of radionuclide for treatment of brain tumors. Stereotact. Funct. Neurosurg. 59, 169-173.
25. 25. United States Pharmacopeia XXIII (1995) United States Pharmacopeial Convention, Rockville, MD, pp. 1221-1222.
26. 32P] chromic phosphate for treatment of solid tumors. APPTLA 46, 103-110.